Niva Bupa Health Insurance Company Limited (NSE:NIVABUPA)
India flag India · Delayed Price · Currency is INR
86.05
+0.31 (0.36%)
Jul 10, 2026, 3:29 PM IST

Niva Bupa Health Insurance Company Earnings Call Transcripts

Fiscal Year 2026

  • Q4 25/26

    GWP grew 27.4% to INR 9,433 crore with 35% retail growth and profit after tax up 80% year-over-year. Combined ratio improved to 101.4%, and the company targets 25% annual growth, leveraging digital and distribution expansion. Retail health loss ratio improved, and industry initiatives are driving transparency.

  • Q3 25/26

    Strong nine-month growth with PAT up 74% year-over-year and market share gains, supported by robust channel performance and digital initiatives. Industry-wide standardization, GST tailwinds, and regulatory clarity are expected to sustain growth and improve cost control.

  • Q2 25/26

    H1 FY '26 saw 23% overall and 28% retail GWP growth, with PAT more than doubling year-over-year. GST reduction to 0% spurred over 50% retail growth in October, while combined and expense ratios improved. Group loss ratio rose due to mix, but retail remained stable.

  • Q1 25/26

    Q1 saw 28% YoY growth (32% in retail), with IFRS PAT nearly doubling to INR 70 crore and combined ratio improving to 103.2%. Loss ratios rose due to reserve increases and group mix, but expense ratios improved; volume growth drove premium gains. Key industry initiatives and tech upgrades support future outlook.

Fiscal Year 2025

  • Q4 24/25

    GWP grew 32% like-for-like to INR 7,406 crores, with IFRS PAT up 21% to INR 203.3 crores. Retail market share rose, group business expanded, and medical inflation was contained at 5%. Solvency and expense ratios improved, with strong digital and distribution growth.

  • Q3 24/25

    Q3 FY25 saw strong premium growth and improved profitability despite a major regulatory-driven accounting transition. Market share in retail health rose, technology adoption advanced, and expense ratios improved, with management confident in meeting future targets.

  • Q2 24/25

    Gross premium grew 36% year-over-year in H1 FY25, with market share gains and IFRS profit more than doubling. Technology and digital channels drove operational efficiency, while regulatory changes and price hikes present ongoing challenges.